BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21772815)

  • 61. High-frequency oscillations (>200 Hz) in the human non-parkinsonian subthalamic nucleus.
    Danish SF; Moyer JT; Finkel LH; Baltuch GH; Jaggi JL; Priori A; Foffani G
    Brain Res Bull; 2007 Sep; 74(1-3):84-90. PubMed ID: 17683793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Parkinsonian Rest Tremor Is Associated With Modulations of Subthalamic High-Frequency Oscillations.
    Hirschmann J; Butz M; Hartmann CJ; Hoogenboom N; Özkurt TE; Vesper J; Wojtecki L; Schnitzler A
    Mov Disord; 2016 Oct; 31(10):1551-1559. PubMed ID: 27214766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Independently together: subthalamic theta and beta opposite roles in predicting Parkinson's tremor.
    Asch N; Herschman Y; Maoz R; Auerbach-Asch CR; Valsky D; Abu-Snineh M; Arkadir D; Linetsky E; Eitan R; Marmor O; Bergman H; Israel Z
    Brain Commun; 2020; 2(2):fcaa074. PubMed ID: 33585815
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PBF509, an Adenosine A
    Núñez F; Taura J; Camacho J; López-Cano M; Fernández-Dueñas V; Castro N; Castro J; Ciruela F
    Front Pharmacol; 2018; 9():1200. PubMed ID: 30405415
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tremor in Multiple System Atrophy - a review.
    Kaindlstorfer C; Granata R; Wenning GK
    Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 24116345
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-dopaminergic treatments for motor control in Parkinson's disease.
    Fox SH
    Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between oscillations in the basal ganglia and synchronization of cortical activity.
    Cassim F; Labyt E; Devos D; Defebvre L; Destée A; Derambure P
    Epileptic Disord; 2002 Dec; 4 Suppl 3():S31-45. PubMed ID: 12495873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The nature of postural tremor in Parkinson disease.
    Dirkx MF; Zach H; Bloem BR; Hallett M; Helmich RC
    Neurology; 2018 Mar; 90(13):e1095-e1103. PubMed ID: 29476038
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Electrocorticography reveals beta desynchronization in the basal ganglia-cortical loop during rest tremor in Parkinson's disease.
    Qasim SE; de Hemptinne C; Swann NC; Miocinovic S; Ostrem JL; Starr PA
    Neurobiol Dis; 2016 Feb; 86():177-86. PubMed ID: 26639855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hereditary progressive dystonia with marked diurnal fluctuation.
    Segawa M
    Brain Dev; 2000 Sep; 22 Suppl 1():S65-80. PubMed ID: 10984664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Computational physiology of the basal ganglia in Parkinson's disease.
    Rivlin-Etzion M; Elias S; Heimer G; Bergman H
    Prog Brain Res; 2010; 183():259-73. PubMed ID: 20696324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
    Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L
    CNS Spectr; 2022 Apr; 27(2):208-217. PubMed ID: 33213556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey.
    Gao DM; Benazzouz A; Piallat B; Bressand K; Ilinsky IA; Kultas-Ilinsky K; Benabid AL
    Neuroscience; 1999 Jan; 88(1):201-12. PubMed ID: 10051201
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.
    Vanover KE; Betz AJ; Weber SM; Bibbiani F; Kielaite A; Weiner DM; Davis RE; Chase TN; Salamone JD
    Pharmacol Biochem Behav; 2008 Oct; 90(4):540-4. PubMed ID: 18534670
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
    Charlton CG; Crowell B
    Mol Chem Neuropathol; 1995 Dec; 26(3):269-84. PubMed ID: 8748929
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physiology of MPTP tremor.
    Bergman H; Raz A; Feingold A; Nini A; Nelken I; Hansel D; Ben-Pazi H; Reches A
    Mov Disord; 1998; 13 Suppl 3():29-34. PubMed ID: 9827591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys.
    Eberling JL; Pivirotto P; Bringas J; Bankiewicz KS
    Exp Neurol; 2000 Oct; 165(2):342-6. PubMed ID: 10993693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans.
    Wachtel H
    J Neural Transm Park Dis Dement Sect; 1991; 3(3):151-201. PubMed ID: 1683537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study.
    Aslam S; Zhang N; Adler CH; Beach TG; Driver-Dunckley E; Mehta SH; Shill H
    Neurol Clin Pract; 2022 Oct; 12(5):e85-e92. PubMed ID: 36380899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.